ARS Pharmaceuticals, Inc. Gain (Loss) on Termination of Lease
ARS Pharmaceuticals, Inc. (SPRY) reported Gain (Loss) on Termination of Lease of $774.00 thousand for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-02.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2022-11-02
- ARS Pharmaceuticals, Inc. gain (loss) on termination of lease for the quarter ending 2022-09-30 was $774.00K.
- ARS Pharmaceuticals, Inc. gain (loss) on termination of lease for the quarter ending 2021-09-30 was $0.00.
| Period end | Gain (Loss) on Termination of Lease 3 month | Gain (Loss) on Termination of Lease 9 month |
|---|---|---|
| 2022-09-30 | $774.00K 10-Q · filed 2022-11-02 | $774.00K 10-Q · filed 2022-11-02 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |